Drugs News and Research

RSS

Cellular protein may be a potential new target for treating osteoporosis

A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

1 Sep 2021

First pharmacological treatment option for patients with a severe form of epilepsy

Epilepsy comes in a variety of forms. Those affected by a genetically de- termined variety have severe epileptic seizures as early as the first year of life.

1 Sep 2021

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.

1 Sep 2021

Do kidney transplant recipients need a third booster dose of mRNA COVID-19 vaccine?

A team of researchers in France have observed that the “standard” 2 dose regimen for mRNA COVID-19 vaccines could provide adequate protection to only a few KTRs. It has also been shown in multiple studies that a considerable population of vaccinated KTRs were easily infected with SARS-CoV-2.

1 Sep 2021

Scientists analyze the prime mechanism for antimicrobial resistance in gonorrhea superbug

The World Health Organization has ranked N. gonorrhoeae as one of 12 antimicrobial-resistant bacterial species that pose the greatest risk to human health, motivating medical researchers around the world to pursue alternative treatments.

1 Sep 2021

Playlist for Life’s new campaign highlights how personal playlists can help people with dementia

Music that gives you that flashback feeling can be a lifeline if you are affected by dementia. Playlist for Life’s ‘Songs for Dementia’ campaign focuses on how personally meaningful music can help the person with dementia to shine through. Put simply, music has the power to shine a spotlight on the ‘me’ in dementia.

1 Sep 2021

Baylor researchers use a faster, more cost-effective technology to discover SARS-CoV-2 inhibitor

Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development of antiviral drugs to treat infected individuals.

1 Sep 2021

Innovative AI and simulation tools used to reveal the inner workings of Sar-CoV-2 virus

Argonne, industry and academia collaborate to bring innovative AI and simulation tools to the COVID-19 battlefront.

1 Sep 2021

Sequential treatment using similar antibiotics can kill bacteria and prevent drug resistance

equential treatment using antibiotics that are similar but swapped around frequently is an effective way to kill bacteria and prevent drug resistance, a study in eLife reports.

1 Sep 2021

Modified R-CODOX-M/IVAC regimen shows promise for treating sporadic Burkitt lymphoma

Burkitt lymphoma (BL) is a highly aggressive form of non-Hodgkin lymphoma (NHL) that comes in three different variants: endemic, immunodeficiency-associated, and sporadic. Of these variants, sporadic BL is most commonly found outside malaria-endemic countries and typically seen in young adults.

1 Sep 2021

New review looks at the bottlenecks and breakthroughs in cancer immunotherapy

After over a century of development, cancer immunotherapy (CIT) has risen to become a promising approach for treating cancer. Unlike conventional methods that try to kill cancer cells directly, CIT involves modifying or stimulating the immune system's natural ability to fight the disease. So far, various CIT treatments have shown remarkable results in terms of survival rates, and many new and combination strategies are currently under study.

1 Sep 2021

COVID-19 associated mucormycosis cases in India

India continues to grapple with the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, the country has reported over one million new cases for the past 28 days.

31 Aug 2021

Walking can power an implantable stimulator device to speed up tendon healing

Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at NUI Galway, have shown how the simple act of walking can power an implantable stimulator device to speed up treatment of musculoskeletal diseases.

31 Aug 2021

New study could help orthopedic surgeons to better identify patients for foot surgery

A new study by researchers at Hospital for Special Surgery in New York City could help orthopedic surgeons better identify which patients will benefit most from surgery to correct debilitating age-related deterioration of their foot arches.

31 Aug 2021

Research offers insights to restore blood vessel integrity during sepsis, other conditions

Sepsis occurs when the body works so hard to fight an infection that the over-activated immune system harms a patient's own tissues as collateral damage.

31 Aug 2021

Researchers develop new drug-free treatment to accelerate healing of chronic diabetic wounds

About one-fourth of people with diabetes develop painful foot ulcers, which are slow to heal due to low oxygen in the wound from impaired blood vessels and increased inflammation. These wounds can become chronic, leading to poor quality of life and potential amputation.

31 Aug 2021

$1.3 million in NIH funding to enable drug delivery technology research

Two National Institute of Health grants totaling over $1.3 million will enable research into antibody-mediated drug delivery technology for the treatment of cancer and autoimmune disorders. L. Nathan Tumey, assistant professor of pharmaceutical sciences at Binghamton University, State University of New York, is the Principal Investigator on both grants - $1.2 million from the National Institute of General Medical Sciences and $150,000 from the National Institute of Allergy and Infectious Diseases.

31 Aug 2021

Researchers develop adult lung organoids that represent all cell types

Since the COVID-19 pandemic reached the United States in early 2020, scientists have struggled to find laboratory models of SARS-CoV-2 infection, the respiratory virus that causes COVID-19. Animal models fell short; attempts to grow adult human lungs have historically failed because not all of the cell types survived.

31 Aug 2021

Hormones play a vital role in the development of breast cancer

A study by RCSI University of Medicine and Health Sciences has provided greater insight into the role that hormones play in the development of breast cancer in patients. The novel findings could enhance the treatment for breast cancer, assisting clinicians in optimising individual patient care and improving overall survival rates for patients.

31 Aug 2021

New research has implications for developing cancer therapies targeting mutant p53 protein

The tumor suppressor protein p53 is mutated in more than half of all human cancers. Several drugs that potentially can restore mutant p53 to its normal cancer-killing function are in clinical investigation.

31 Aug 2021

Drugs News and Research

Cellular protein may be a potential new target for treating osteoporosis

First pharmacological treatment option for patients with a severe form of epilepsy

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

Do kidney transplant recipients need a third booster dose of mRNA COVID-19 vaccine?

Scientists analyze the prime mechanism for antimicrobial resistance in gonorrhea superbug

Playlist for Life’s new campaign highlights how personal playlists can help people with dementia

Baylor researchers use a faster, more cost-effective technology to discover SARS-CoV-2 inhibitor

Innovative AI and simulation tools used to reveal the inner workings of Sar-CoV-2 virus

Sequential treatment using similar antibiotics can kill bacteria and prevent drug resistance

Modified R-CODOX-M/IVAC regimen shows promise for treating sporadic Burkitt lymphoma

New review looks at the bottlenecks and breakthroughs in cancer immunotherapy

COVID-19 associated mucormycosis cases in India

Walking can power an implantable stimulator device to speed up tendon healing

New study could help orthopedic surgeons to better identify patients for foot surgery

Research offers insights to restore blood vessel integrity during sepsis, other conditions

Researchers develop new drug-free treatment to accelerate healing of chronic diabetic wounds

$1.3 million in NIH funding to enable drug delivery technology research

Researchers develop adult lung organoids that represent all cell types

Hormones play a vital role in the development of breast cancer

New research has implications for developing cancer therapies targeting mutant p53 protein

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News